CL vs PEP: How Colgate-Palmolive and PepsiCo Compare (2026)

Same yardstick, side by side (as of July 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: PEP is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CL and PEP share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CL and PEP exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Colgate-Palmolive is a global consumer-staples company that makes everyday household and personal-care products. It is a worldwide leader in oral care, where its Colgate-branded toothpaste, toothbrushes, and mouthwash hold a leading global share, and it also sells personal care (soaps, body wash, deodorants under brands like Palmolive, Softsoap, Irish Spring, and Sanex), home care (dish and surface cleaners such as Palmolive and Ajax), and pet nutrition through its Hill's Pet Nutrition business (Science Diet and Prescription Diet). Colgate makes money by selling these branded, frequently repurchased products at scale across more than 200 countries and territories, with a particularly large presence in emerging markets. Its competitive advantages come from powerful brands, vast distribution, and pricing power on staple goods. Headquartered in New York City, Colgate is a defensive, dividend-paying company whose products people buy regardless of the economic cycle.

Full CL guide

PepsiCo is one of the world's largest food and beverage companies, generating roughly $19.4 billion in the first quarter of 2026 across a portfolio that spans Pepsi, Gatorade, Mountain Dew, Lay's, Doritos, Cheetos, Tostitos and Quaker. Its Frito-Lay snack arm controls more than 60% of the U.S. salty-snacks market and carries operating margins north of 40%, making convenient foods the company's profit engine, while its beverage unit holds the No. 2 spot in U.S. carbonated soft drinks (behind Coca-Cola) and leads sports drinks with Gatorade. Roughly half of revenue comes from foods and the business is spread across North America and fast-growing international markets.

Full PEP guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CL drivers: Oral-care leadership and emerging markets; Hill's Pet Nutrition growth.
• PEP drivers: Frito-Lay snack moat; Volume recovery and value pricing.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Colgate's growth is structurally slow: it competes in mature, saturated staples categories where volume gains are hard to come by and much of recent revenue growth has come from price increases that may not persist. For PEP, pepsiCo faces several structural headwinds.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CL if you believe its drivers more; PEP if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CL and PEP guides.

CL. Colgate trades at a premium consumer-staples multiple that reflects its defensive, recession-resistant cash flows, leading oral-care brands, the growth of Hill's, and a multi-decade dividend-raising record. The valuation premium is the market paying for stability and pricing power, balanced against the reality of slow underlying volume growth in mature categories.

PEP. PepsiCo grew Q1 2026 revenue about 8.5% year over year to roughly $19.4 billion with core EPS near $1.61, beating estimates and expanding operating margin to about 17%. At around $143 (July 2026) the stock sits roughly 15% below its February high near $171 and trades at about 16x forward earnings, below the S&P 500 average, while yielding close to 4%. The valuation reflects a market pricing in slow growth in exchange for defensive stability and reliable income.

Headline figures (approximate, early 2026): CL shows revenue (ttm) ~$20 billion, operating margin ~20-21%, net income (ttm) ~$2.7 billion, dividend yield ~2-2.5% (Dividend King); PEP shows q1 2026 revenue ~$19.4B, q1 2026 core eps ~$1.61, market cap ~$195B, forward p/e ~16x.

CL and PEP are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CL and PEP exposure against your real portfolio. It is not an investment adviser.